|
INVS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52100554373646E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69886327228141E-12 |
| Normal-vs-Stage2 |
3.67510466503518E-11 |
| Normal-vs-Stage3 |
3.44169137633799E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
9.384400E-01 |
| Stage1-vs-Stage3 |
1.259220E-01 |
| Stage1-vs-Stage4 |
3.639800E-03 |
| Stage2-vs-Stage3 |
2.884200E-01 |
| Stage2-vs-Stage4 |
3.872100E-02 |
| Stage3-vs-Stage4 |
1.870800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.43929354282591E-15 |
| Normal-vs-AfricanAmerican |
1.44889999997844E-06 |
| Normal-vs-Asian |
2.16950002407401E-09 |
| Caucasian-vs-AfricanAmerican |
9.964400E-02 |
| Caucasian-vs-Asian |
3.429800E-02 |
| AfricanAmerican-vs-Asian |
9.644600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1094237467878E-15 |
| Normal-vs-Female |
3.05311331771918E-14 |
| Male-vs-Female |
2.181000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.73483449827927E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63313806922361E-12 |
| Normal-vs-Age(81-100Yrs) |
2.10429999999429E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.760000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.265000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.470600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.173200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.853000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.150800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.287900E-02 |
| Classical-VS-Follicular |
6.443000E-01 |
| Classical-VS-Other |
4.671800E-01 |
| Classical-VS-Normal |
1.75082170983387E-12 |
| Tall-VS-Follicular |
2.564400E-02 |
| Tall-VS-Other |
6.748200E-01 |
| Tall-VS-Normal |
2.00950367457153E-14 |
| Follicular-VS-Other |
4.997600E-01 |
| Follicular-VS-Normal |
2.96052071746544E-12 |
| Other-VS-Normal |
1.550870E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63613567139009E-12 |
| Normal-vs-N1 |
1.90958360235527E-14 |
| N0-vs-N1 |
3.128800E-01 |
|
|
